World Health Organization and has already been cleared for use in 17 countries. Covaxin has joined the anti-Covid vaccines produced by Pfizer/BioNTech, Moderna, AstraZeneca, Johnson&Johnson, Sinopharm, and Sinovac on the WHO-approved list.
The UN body has described it as "extremely suitable for low- and middle-income countries due to easy storage requirements". However, more research would be required to discover Covaxin's long-term safety and effectiveness, as well as protection against hospitalisation, death, along with its ability to fend off Covid delta variant and other variants of concern, The Lancet added.Never miss a story!